StonvexLoading…
StonvexCore line items from APD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $12.04B | $12.10B | $12.60B | $12.70B |
Operating Income | $-877.00M | $4.47B | $2.49B | $2.34B |
Net Income | $-394.50M | $3.83B | $2.30B | $2.26B |
EPS (Diluted) | $-1.77 | $17.18 | $10.33 | $10.14 |
Total Assets | $41.06B | $39.57B | $32.00B | $27.19B |
Total Liabilities | $23.71B | $20.90B | $16.34B | $13.49B |
Cash & Equivalents | $1.86B | $2.98B | $1.62B | $2.71B |
Free Cash Flow OCF − CapEx | $-3.77B | $-3.15B | $-1.42B | $244.10M |
Shares Outstanding | 222.59M | 222.37M | 222.20M | 221.84M |